MORSE Consulting offers ongoing strategic advice to optimize the prospect of reimbursement success throughout the Canadian pharmaceutical lifecycle.
MORSE Consulting develops tailored reimbursement assessments and analyses to meet a client’s evolving needs – from comprehensive reimbursement landscape assessments to detailed time-to-listing analyses.
MORSE Consulting organizes, facilitates, and participates in numerous types of advisory boards. This includes negotiation simulation sessions which help clients gauge payer reaction to a range of proposals.
MORSE Consulting delivers training sessions on the Canadian pharmaceutical reimbursement environment that can be customized for various target audiences.
Toronto, September 18, 2019 – MORSE Consulting is pleased to launch the Canadian Reimbursement Trends and Timelines report – a comprehensive, credible and relevant source of market access … Read More →
pan-Canadian Pharmaceutical Alliance (pCPA): August 2019 Trends and Insights The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the August 31, 2019 status of brand negotiations. Highlights since the … Read More →
Introduction MORSE Consulting is pleased to contribute its pCPA/public payer expertise with leading pricing and reimbursement experts and provide our respective views on how the new PMPRB regulations … Read More →